Depixus is developing a set of technologies to enable the rapid, precise and inexpensive extraction of genetic and epigenetic information from single DNA and RNA molecules. Many of Depixus' technologies are already at an advanced validation stage and commercial development is underway. The company enjoys the strong support of a group of experienced investors, including several from the sequencing industry.
Establishment: ENS - PSL, UdP, SU, CNRS
Original laboratory: Statistical Physics Laboratory (UMR 8550), ENS - PSL
CEO: Gordon Hamilton
